Treatment
Treatment literacy materials that cover the basics of hepatitis C treatment, research on efficacy in different key populations, and global treatment uptake.
Materials in this section
JAMA Paper: In People with Opioid Use Disorder, Telemedicine Treatment for HCV Was More Than Twice as Successful as Off-Site Referral
The study is one of only a few randomized controlled trials that have been conducted to determine the effectiveness of using telemedicine to improve health care access for vulnerable populations. More
Rapid Communication: Co-Administration of Treatment for Drug-Resistant TB and Hepatitis C
WHO announces forthcoming updates on co-administration of treatment for drug-resistant TB and hepatitis C. More
Telemedicine at Syringe Access Programs May Address Barriers, Expand Access to HCV Treatment
A survey found telemedicine-based HCV treatment at a syringe access program could improve access to treatment among people who inject drugs. More
Self-Reported and Objective Compliance for HCV Treatment Reflect Different Cure Rates
Study exposes the adherence gap in HCV direct-acting antiviral therapy among people who inject drugs. More
People Who Inject Drugs Report Unique Barriers to Hepatitis C Treatment
A Toronto study analyzes differences in hepatitis C treatment experiences based on drug use. More
How Does the Risk of Hepatocellular Carcinoma Change Over Time in Patients with a Hepatitis C Cure?
An editorial seeks to answer this important question, which has implications for surveillance guidelines, patient counselling and the development of HCC risk models. More
Changes in Inflammatory Cytokines After Chronic Hepatitis C Treatment Among People Living With HIV
A study evaluates the effect of hepatitis C virus cure on serum inflammatory markers among people with HIV. More
Barriers to HCV Treatment Initiation in People with a History of Illicit Substance Use
A qualitative interview study assesses pertinent barriers to HCV treatment in ambulatory patients with a history of illicit substance use. More
Scale-Up of Direct-Acting Antiviral Treatment in Prisons is Both Cost-Effective and Key to HCV Elimination
A study in Australia evaluated the cost-effectiveness of scaling-up HCV treatment in state-wide prison services incorporating long-term outcomes across custodial and community settings. More
Implicit Bias from Providers Inhibits HCV Treatment
A new study reveals significant insights into the challenges that can occur for hepatitis C micro-elimination efforts in people with HIV in the United States. More
